Wednesday, July 31, 2013 11:14:42 AM
VENTURE:RBX)(FRANKFURT:RB4) announces that the Autorite des marches financiers
and the British Columbia Securities Commission have granted to Robex a full
revocation of their cease trade orders on the securities of Robex following the
filing of the audited annual financial statements, Chief Executive Officer and
Chief Financial Officer certifications under Regulation 52-109 respecting
Certification of Disclosure in Issuers' Annual and Interim Filings and
management discussion and analysis for the year ended December 31, 2012 of Robex
(collectively, the "Annual Disclosure Documents"). The Corporation has been
advised by the TSX Venture Exchange that its common shares will be reinstated
for trading effective on the opening of market on May 27, 2013. The reason for
the issuance of the cease trade orders and trading suspension was the late
filing of the Annual Disclosure Documents.
This press release contains statements that may constitute "forward-looking
information" or "forward-looking statements" as set out within the context of
security law. This forward-looking information is subject to many risks and
uncertainties, some of which are beyond Robex Inc.'s ("Robex") control. The
actual results or conclusions may differ considerably from those that have been
set out, or intimated, in this forward-looking information. There are many
factors which may cause such disparity, especially the instability of metal
market prices, the results of fluctuations in foreign currency exchange rates or
in interest rates, poorly estimated reserves, environmental risks (stricter
regulations), unforeseen geological situations, unfavorable extraction
conditions, political risks brought on by mining in developing countries,
regulatory and governmental policy changes (laws and policies), failure to
obtain the requisite permits and approvals from government bodies, or any other
risk relating to mining and development. There is no guarantee that the
circumstances anticipated in this forward-looking information will occur, or if
they do occur, how they will benefit Robex. The forward-looking information is
based on the estimates and opinions of Robex's management at the time of the
publication of the information and Robex does not assume any obligation to make
public updates or modifications to any of the forward-looking statements,
whether as a result of new information, future events, or any other cause,
except if it is required by securities laws.
FOR FURTHER INFORMATION PLEASE CONTACT:
Augustin Rousselet
Interim Chief Financial Officer
418-527-5023
info@robexgold.com
All my posts, are only My Opinion
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM